Managing the Pharmaceutical Supply Chain in Mauritius' Public Sector
Managing The Supply Chain For Pharmaceuticals In the Public Sector | 26 avril
2011
| Aiming to guarantee the continuous flow of products from the point of manufacture to the point where they are used by consumers. | Sarita Pulton Boolell |
Country & DEVELOPMENT A. Introduction
The leitmotiv of the supply chain for pharmaceuticals in the Public Service is the six RIGHTS:
The right pharmaceutical
In the right quantity
Of the right quality
At the right place
At the right time
At the right cost
In other words we aim to procure and supply drugs in the most efficient, safest and least costly way possible.
However, it must be understood the drugs used in a country is normally the exact reflection of the prevalent diseases. The epidemiological landscape is ,very often, a less thought influencing factor on the Pharmaceutical Supply Chain logistics .
In a country where non- communicable chronic diseases represent the biggest health burden, the supply chain needs to guarantee ,in priority, the continuous flow of drugs ,being given that the stabilization of a condition will depend above all of the patient’s continuous compliance to his treatment.
Chronic diseases also imply that the patient once started on a medication will have to take it for a life time.
Among other influencing factors are the level of training of the Health Care personnel in supply chain , the number of distribution points, the legal framework ,the procurement methods, the policy and political decisions for the pharmaceutical sector.
We aim in this report to critically examine the different operations of the Supply Chain for pharmaceuticals in the Public Sector.
B. Country Background
With a per capita income of about US$ 260 at the time of independence in 1968, Mauritius emerged from an under-developed economy to that of an upper middle income economy. In
2006 Mauritius had a per capita income of US$ 6431 or $11 643 in purchasing power
2011
| Aiming to guarantee the continuous flow of products from the point of manufacture to the point where they are used by consumers. | Sarita Pulton Boolell |
Country & DEVELOPMENT A. Introduction
The leitmotiv of the supply chain for pharmaceuticals in the Public Service is the six RIGHTS:
The right pharmaceutical
In the right quantity
Of the right quality
At the right place
At the right time
At the right cost
In other words we aim to procure and supply drugs in the most efficient, safest and least costly way possible.
However, it must be understood the drugs used in a country is normally the exact reflection of the prevalent diseases. The epidemiological landscape is ,very often, a less thought influencing factor on the Pharmaceutical Supply Chain logistics .
In a country where non- communicable chronic diseases represent the biggest health burden, the supply chain needs to guarantee ,in priority, the continuous flow of drugs ,being given that the stabilization of a condition will depend above all of the patient’s continuous compliance to his treatment.
Chronic diseases also imply that the patient once started on a medication will have to take it for a life time.
Among other influencing factors are the level of training of the Health Care personnel in supply chain , the number of distribution points, the legal framework ,the procurement methods, the policy and political decisions for the pharmaceutical sector.
We aim in this report to critically examine the different operations of the Supply Chain for pharmaceuticals in the Public Sector.
B. Country Background
With a per capita income of about US$ 260 at the time of independence in 1968, Mauritius emerged from an under-developed economy to that of an upper middle income economy. In
2006 Mauritius had a per capita income of US$ 6431 or $11 643 in purchasing power